Connect your AI

CalAmp CAMP Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Ionis PharmaceuticalsIONS

——

Polaryx Therapeutics, Inc. PLYX

——

Recursion Pharmaceuticals, Inc.RXRX

——

Other financials

Income statement

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CalAmp's accrued manufacturing costs?: CalAmp (CAMP) reported accrued manufacturing costs of $945K in Q1 2026.
How has CalAmp's accrued manufacturing costs changed year-over-year?: CalAmp's accrued manufacturing costs increased by 21.0% year-over-year, from $781K to $945K.